Caris Life Sciences CEO on IPO debut, using AI to fight against cancer

2 Views
Published
David Dean Halbert, Caris Life Sciences chairman, founder and CEO, joins 'Squawk Box' to discuss the company's IPO debut, how the company uses AI technology to help diagnose and treat cancer,
Category
Oncology
Be the first to comment